Brain circulation · 2025
Exacerbation of hemorrhagic stroke and impaired hemostasis in mice deficient of the integrated stress response kinase heme-regulated inhibitor.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Slomnicki Lukasz P, Owens Rachel L, Hodges Emily R, McNeely Jordan, Burke Darlene A, Chariker Julia H, Rouchka Eric Christian, Ohri Sujata Saraswat, Ding Dale, Hetman Michal
Аннотация
BACKGROUND: Heme-regulated inhibitor (HRI/EIF2AK1) is a protein kinase that initiates the integrated stress response (ISR) following mitochondrial damage and/or oxidative stress. Dependent on a context, ISR may promote death or recovery of cells under stress. This study was initiated to determine HRI contributions to brain damage after experimental intracerebral hemorrhage (ICH) where oxidative toxicity of hemoglobin is a major trigger of neural cell loss.
MATERIALS AND METHODS: Publicly available transcriptomic data from a mouse model of ICH were analyzed using standard bioinformatic tools. Hri-/- and wild-type control mice were subjected to unilateral collagenase-induced ICH followed by evaluation of forelimb functional deficits (adhesive tape removal), brain histology (Fluoro-Jade B staining of degenerating neurons and immunofluorescence for GFAP and CD36), and extravasated brain hemoglobin assays. Tail bleeding time and platelet number were determined to assess hemostasis.
RESULTS: ISR transcripts were robustly overrepresented in the transcriptome of the peri-hematoma region of wild-type mice at 1-day post-ICH induction, suggesting acute ISR activation. After ICH, Hri-/- mice showed greater impairment of forelimb function and exacerbated brain damage as indicated by increases of (1) GFAP-negative lesion area, (2) number of degenerating neurons, and (3) signal area of the activated macrophage marker CD36. These effects correlated with acute increases of hemoglobin extravasation, lower platelet counts, and prolonged tail bleeding.
CONCLUSIONS: While ISR is activated by ICH and may play a role in secondary injury, impaired hemostasis is a likely driver of enhanced ICH severity in Hri-/- mice.
MATERIALS AND METHODS: Publicly available transcriptomic data from a mouse model of ICH were analyzed using standard bioinformatic tools. Hri-/- and wild-type control mice were subjected to unilateral collagenase-induced ICH followed by evaluation of forelimb functional deficits (adhesive tape removal), brain histology (Fluoro-Jade B staining of degenerating neurons and immunofluorescence for GFAP and CD36), and extravasated brain hemoglobin assays. Tail bleeding time and platelet number were determined to assess hemostasis.
RESULTS: ISR transcripts were robustly overrepresented in the transcriptome of the peri-hematoma region of wild-type mice at 1-day post-ICH induction, suggesting acute ISR activation. After ICH, Hri-/- mice showed greater impairment of forelimb function and exacerbated brain damage as indicated by increases of (1) GFAP-negative lesion area, (2) number of degenerating neurons, and (3) signal area of the activated macrophage marker CD36. These effects correlated with acute increases of hemoglobin extravasation, lower platelet counts, and prolonged tail bleeding.
CONCLUSIONS: While ISR is activated by ICH and may play a role in secondary injury, impaired hemostasis is a likely driver of enhanced ICH severity in Hri-/- mice.